madman
Super Moderator
OG in the field here!
Dr. Christina Wang
Q&A
EmpowHER the Patient is a podcast series highlighting the accomplishments and attitudes of change makers advancing women’s health and empowerment across Los Angeles.
This first episode of the series features Dr. Christina Wang who is a Senior Investigator at The Lundquist Institute located next to Harbor-UCLA Medical Center and a distinguished Professor of Medicine at UCLA.
She serves as Senior Associate Director and Site Leader for the UCLA Clinical & Translational Science Institute (CTSI) at the Lundquist/Harbor-UCLA site.
Her research focuses on male reproductive endocrinology, including hormonal male contraception, androgen replacement therapy, and spermatogenesis regulation.
She leads and collaborates on clinical trials translating hormonal and metabolic discoveries into therapies that advance men’s reproductive and overall health.
In this episode, we explore the implications of a new male contraceptive topical entering Phase 3 in clinical trials and the feedback from research participants as the drug inches closer to approval to be sold in the pharmaceutical market.
We discuss how the topical will revolutionize family planning responsibility and enhance reproductive health equity.
Dr. Christina Wang
Q&A
EmpowHER the Patient is a podcast series highlighting the accomplishments and attitudes of change makers advancing women’s health and empowerment across Los Angeles.
This first episode of the series features Dr. Christina Wang who is a Senior Investigator at The Lundquist Institute located next to Harbor-UCLA Medical Center and a distinguished Professor of Medicine at UCLA.
She serves as Senior Associate Director and Site Leader for the UCLA Clinical & Translational Science Institute (CTSI) at the Lundquist/Harbor-UCLA site.
Her research focuses on male reproductive endocrinology, including hormonal male contraception, androgen replacement therapy, and spermatogenesis regulation.
She leads and collaborates on clinical trials translating hormonal and metabolic discoveries into therapies that advance men’s reproductive and overall health.
In this episode, we explore the implications of a new male contraceptive topical entering Phase 3 in clinical trials and the feedback from research participants as the drug inches closer to approval to be sold in the pharmaceutical market.
We discuss how the topical will revolutionize family planning responsibility and enhance reproductive health equity.
